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ABSTRACT                         
Objectives: Emergence of antibiotic resistance is an important 
problem in microbial infection control. Certain enzymes can lead 
to resistances against the third generation cephalosporins by the 
hydrolysis of monobactams. This study was conducted to evaluate 
antibiotic sensitivity profiles and the presence of bla
TEM 
 gene in   E. 
coli isolates collected from clinical specimens of Ostad Alinasab 
Hospital in Tabriz.
Materials and Methods: E. coli (100 isolates) were detected 
by using conventional bacteriologic tests and then antibiotic sen-
sitivity tests were performed according to Kirby-Bauer method. 
Confirmatory test was also performed by combined disk test meth-
od. Finally bla
TEM
 gene was detected by using polymerase chain 
reaction (PCR) technique. 
Results: Our fo 100 E. coli 23% of isolates   contained bla
TEM
 
gene. 18% of isolates were resistant to ceftazidime, while 30% of 
isolates were resistant to cefotaxime and the remaining was sensi-
tive.  46% of isolates were ESBL producers from which 23% of 
them contained bla
TEM
 gene.
Conclusion: High resistance of E. coli isolates to the third 
generation cephalosporins underlines need for accurate sensitivity 
tests, also avoidance from inappropriate use of antibiotics.                                    
 Keywords: Extended-spectrum beta-lactamases (ESBLs), bla
TEM
 
gene,   Escherichia coli, Polymerase chain reaction
ÖZ
Amaç: Antibiyotik direncinin gelişmesi bakteriyel enfeksiyon-
ların kontrolünde önemli bir sorundur. Bu çalışma, antibiyotik 
duyarlılık profillerini değerlendirmek ve Tebriz’de Ostad Alinasab 
Hastane’sinin klinik örnekleriden elde edilen E.coli izolatlarında 
bla
TEM 
 geni varlığını değerlendirmek amacıyla planlanmıştır. 
Gereç ve Yöntemler: E.  coli (100 izolatları) geleneksel bak-
teriyolojik testler ile elde edilmiş ve daha sonra antibiyotic du-
yarlılık testleri Kirby-Bauer yöntemine göre  değerlendirilmiştir. 
Doğrulayıcı testler ise “Combinde disk” testleri ile gerçekleştir-
ilmiştir. Son olarak bla
TEM 
 geni varlığı polymeraz zincir reaksiyon 
(PCR) tekniği kullanılarak değerlendirilmiştir. 
Bulgular: Yüz E.  coli izolatından %23’nün blaTEM geni-
ni içerdiği belirlenmiştir. İzolatlarının %18’inde Seftazidim, % 
30’unda sefotaksim direnci saptanmıştır. Izolatların % 46’sında 
EBSL sentezi belirlenmiş ve bu izolatların % 23’de de blaTEM 
geninin varlığı saptanmıştır. 
Sonuç: E. coli izolatlarında saptanan üçüncü kuşak sefalospo-
rinlere karşı yüksek direnç uygunsuz antibiyotik kullanımından 
kaçınılması gerektiğinin ve tedavi öncesi doğru duyarlılık testleri-
nin uygulanması gerektiğinin önemin göstermektedir.  
Anahtar kelimeler: Geniş spektrum beta-laktamaz (GSBL), 
blaTEM geni, Escherichia coli, Polimeraz zincir reaksiyonu 
Introduction
Since sulfonamides and penicillin first appeared, a new 
opportunity was created in treatment of diseases. In the early 
days of application of these medicines, they could suppress 
numerous pernicious epidemics. However, diseases resulting 
from infectious organisms still remain as a serious challenge 
[1,2]. There are two important mechanisms through which 
resistance to antibiotics and other medicines emerge. The 
first one occurs as a result of a spontaneous mutation at 
approximately 10-5 Hz, which alters sensitivity to medicine, 
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changes it into a merely selective agent and enables tolerant 
organisms to survive [1-3]. The second mechanism is 
to create resistance in genetic exchange wherein genetic 
information can control bacterial resistance transferred from 
a (resistant) cell to another (sensitive) by transformation, 
conjugation and transduction [2-4]. Hospitalized patients are 
exposed to hospital infections particularly organisms resistant 
to some medicines (gram negative bacillus species) as a 
major infection agent and its associated fatality [1,4]. Since 
antibiotics are especially prescribed in intensive care units 
(ICU) to accelerate the natural treatment process, the problem 
become more serious, thus, having hydrolysis potential, a 
wide variety of extended-spectrum beta-lactamases (ESBLs), 
ESBL-generating strains (Beta-lactamase) used in clinics are 
of critical importance. ESBL-generating bacteria together 
with AmpC-encoded class C cephalosporinase are the most 
common resistance mechanism of gram positive bacillus to 
this antibiotic [5-7]. Since the second half of 1980s, when 
ESBLs and their widespread geographic distribution of 
these enzymes, they were introduced as an epidemiological 
phenomenon [8]. This paper focuses on clinical isolates of E. 
coli collected from Ostad Alinasab Hospital in Tabriz in order 
to propose a sensitivity pattern to the analyzed antibiotics and 
to study their molecular structure to check presence of blaTEM 
from ESBLs. 
Materials and Methods 
Various clinical specimen including mucus, urine, blood, 
tracheal tube secretions, wound secretions, throat secretions, 
catheter, cerebro spinal fluid, ascites, and peritoneal fluid 
were collected from hospitalized and outpatients of  Ostad 
Alinasab Hospital in Tabriz by Simple Random Sampling 
method. 
The bacteria extracted from patients’ specimen were 
purified using MacConkey Agar, Blood Agar. Then, they 
were identified routinely by using citrate, urea, MR, VP, 
Triple Sugar Iron Agar (TSI) and SIM culture (all culture 
media were made by Merck) [9].  
Combined Disk Test 
This test was conducted by using ceftazidime disk (30μg), 
cefotaxime (30μg), ceftazidime/clavulanic acid (30μg/10μg) 
and cefotaxime/clavulanic acid (30μg/10μg) made in Mast 
Company. To conduct this test, suspension isolates equal 
to 0.5 McFarland standard turbidity were prepared. They 
were, then cultured by cotton swabs on Muller Hinton Agar 
in three orientations, and the aforementioned disks were 
superimposed. Growth inhibition zone around the disks were 
recorded after 24 hour incubation at 37 ºC. over 5mm increase 
in the size of growth inhibition zone around ceftazidime/
clavulanic acid (30μg/10μg) and cefotaxime/clavulanic 
acid (30μg/10μg) in comparison to that of ceftazidime disks 
(30μg) and cefotaxime (30μg) indicated ESBL samples are 
positive and the result proved positive (Fig1.1). In this test, 
negative control strain was E. coli ATCC 25922 and negative 
control strain was E. coli ATCC 35218 [9].
Diag. 1.1- Sensitivity test of E.  coli isolates to ceftazidime using 
Disk Agar Diffusion
Diag. 1.2- Sensitivity test of E. coli isolates to cefotaxime using 
Disk Agar Diffusion
Figure1.1. Schematic representation of increase in the size of 
growth inhibition zone in E. coli isolates using Combined Disk 
method for isolate no.139. 
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DNA Isolation and PCR Cloning: 
First, DNA plasmids were isolated by using Bioneer Kit 
based on the guidelines of the manufacturing company 
(RTP® Bacteria DNA Mini Kit). Then, polymerase chain 
reaction (PCR) test was conducted to identifiy beta lactamase 
bla
TEM
 under the following circumstances (Table I). Table 
II shows the primers used in PCR analysis. Also, negative 
control strain was E. coli ATCC 25922 and negative control 
strain was E. coli ATCC 35218. Poly acryl amid gel %12 
and SMO323 Ladder (Fermantase as Size Marker) were 
used to electrophorese  PCR products [10-12].
Table I. Terms used in PCR
Test procedure
 Temperature 
( ° C )
Time
Initial denaturation step 94   4 min
Denaturation step 94   1 min
Annealing step 53 45 min
Extension/elongation 
step
72    1 min
Final extension/
elongation step
72 10 min
Number of cycles 35
Table II. Primers used in PCR reactions for beta lactamase gene 
type TEM (M.pornour et al 2010) 
Nucleotide sequence  Gene sequence
ACA TGG GGG ATC ATG 
TACT-3  -  5  
Forward -
5- GAC AGT TAC 
AAT GCT TACT-3  
Reverse -
Results
A hundred  isolates of E. coli  consisted of  the following 
numbers of samples: 80 urine (80%), 10 tracheal tube 
secretions (10%), 7 blood culture (7%),  1 catheter (1%), 
1 pleural fluid (1%), and 1 mucus (1%). 18 isolates (18%) 
were ceftazidime-resistant, 30 were cefotaxime-resistant 
and the rest were sensitive. Also, 46 isolates (46%) were 
ESBL-positive. Of 100 isolates tested for PCR, 23 (23%) 
contained bla
TEM
. In this paper, an isolate containing bla
TEM 
was identified, which was ESBL negative (Figure 2.).
Figure2.1. Results of PCR reaction in search for positive control 
(no.3) and negative control (no.4) bla
TEM
 gene  
Nos.2, 1, 5 contain bla
TEM
 gene  
No.6 lacks bla
TEM
 gene  
Figure2.2. schematic representation of bla
TEM
 containing isolates 
No.7 contains blaTEM gene and Nos. 12, 11, 10, 9, 8 lack it 
Figure2.3.  schematic representation of blaTEM containing isolates 
Nos.18, 17, 13 contains blaTEM gene and Nos. 16, 15, 14 lack it
Figure2.4.  schematic representation of blaTEM containing 
isolates Nos.23, 22, 21, 20, 19 contain blaTEM gene and 
No.24 lacks it
Thorough examinations of E.coli isolates suggested 
that  for ceftazidime: of 23 bla
TEM
-containing isolates, 20 
(86.9%) were resistant and 3 were sensitive (13.1%).   For 
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cefotaxime: of of 23 bla
TEM
-containing isolates, 21 (88.89%) 
resistant and 6 sensitive (13.1%). Of 100 tested E. coli, one 
isolate was bla
TEM
-lacking and cefotaxime-resistant (2.44%) 
and 2 lacked bla
TEM
 with intermediate resistance (4.88%). 
For ceftazidime / clavulanic acid, of 23 tested isolates 
containing bla
TEM
, 21 showed increase in the size of growth 
inhibition zone (91.3%).  For cefotaxime / clavulanic acid, 
of 23 tested isolates containing bla
TEM
, 20 showed increased 
growth inhibition zone (91.3%).  Of 100 E.coli isolates 
tested, one blaTEM-containing isolate showed no increase 
when exposed to either ceftazidime / clavulanic acid or 
cefotaxime / clavulanic acid  (Figure 1)
Discussion 
Extended-spectrum beta-lactamases (ESBLs)  are able to 
hydrolyze most commonly used beta-lactam antibiotics. 
Therefore, they are referred to as ESBLs. Seemingly, 
ESBLs are inherently produced by class C chromosomal 
gene cephalosporinase (Ampc) and participate in creating 
resistance mechanisms in gram negative bacteria. Given 
these descriptions, ESBLs are class A or D beta lactamase 
molecules that can hydrolyze oxy-imino-cephalosporins 
10% or more than that of benzylpenicillin. The organisms 
carrying these genes increase pathogenicity [1,9]. 
In a similar study conducted by Mazinani and colleagues 
in 2008 in Vali Asr Hospital, Tehran, 47 isolates of 76 
clinical samples (60%) contained TEM gene [13]. Masjedian 
showed that, 84.6% of 148 E.coli strains contained TEM 
isolates [14].  Mirsalehian et al.  suggested that 39.45% of 
E.coli strains contained beta lactamase TEM isolates [15]. 
A comparison made between the present study and above 
studies indicates high prevalence of this enzyme type in 
E.coli strains in Iran. A study performed by Bradford in 
the United States showed that TEM beta lactamase has the 
highest abundance of ESBLs enzymes [15,16].
Between  2001 and  2006, Hong Fang showed that among 
87 E.coli isolates phenotypically known as ESBL producers 
in Sweden, 63% had beta lactamase genotype [17], while in 
the present paper 46% of the isolates were ESBL positive and 
50% of ESBL producers had a TEM type genotype. In Spain, 
Emilio David Valverde revealed that 30% of E.coli samples 
taken from 11272 patients of Salamanca Hospital produced 
ESBLs, which TEM family was 22.1% [18]. However, 
recent literature increased levels of ESBLs throughout the 
world.  For example, distribution of ESBLs was as follows: 
Northern America: K. pneumonia (4.2%-4.4%), E. coli 
(3.3%-4.7%), P. mirabilis (3.1%-4.7%). Far-East-Western 
region: K. Pneumoniae (11.3%-51%), E. coli (9.9%-23.6%), 
Salmonella  (3.4%) and P. mirabilis (1.8%). Europe: 
expansion and prevalence of ESBL in Enterobacteriaceae in 
1610 E.coli and 785 K. pneumoniae specimen collected from 
31 stations of 10 European countries varied from 1%-5% 
in Northern Europe (Germany) to almost 39%-47% in East 
Europe (Russia, Poland, Turkey). In a joint study compiled 
by Paul-Ehrlich-Gesellschaft (PEG) in 2001, protein extracts 
from 8.2% of K. pneumonia, 0.8% of 612 E.coli, and 1.3% 
of 152 K. oxytoca specimen contained ESBL [8,9,19], while 
ESBL was 46% in the present paper.  Overconsumption of 
antibiotics particularly ceftazidime, hospitalization in ICU 
wards, and excessive uses of urinary catheter are all factors 
of breaking out ESBLs. The results of research in recent 
years on ESBL producing E.coli various strains in different 
countries are: Pakistan 53.3%  (2006),  India 68%  (2002), 
Spain 51.8% (2005), South Korea 9.2% (2004), Lebanon 
13.3% (2005),  Israel 22% (2005), Germany 10.3%  (2005), 
France 4% (2006),  Turkey 17% (2004),  Bangladesh 43.2% 
(2004), United States 2%-10% (2003),  China 13%-35% 
(2002)  [20] .
Eslamy et al  studied breakout of extended-spectrum 
beta-lactamases (ESBLs) on 200 isolates of E. coli collected 
from hospitals in Arak City by combined disk phonotypical 
method,  which suggested that 47% ESBL were positive [9], 
similar to the present paper.  Pornour et al (2010) classified 41 
E.coli isolates in terms of resistance to medications:   87.8% 
resistant to Aztreonam, 80.49% to piperacillin/tazobactam 
and ceftazidime, 78.05% to cefotaxime, cefuroxime and 
ceftriaxone, 65.85% to cefepime, and 4.88% to amikacin. 
But none of these isolates resisted Imipenem. Also, 97.56% 
of ESBL was positive and 36 out of 41 isolates under PCR 
reaction (87.8%) contained TEM beta lactamase gene. In 
our research, the resistance to Ceftazidime and Cefotaxime 
were 86.9% and 88.89%, respectively (20).    Soltandallal et 
al (2010) found that 57.8% of 200 E.coli isolates contained 
TEM genes [21].  Zaman zad and colleagues (2008) reported 
that abundance of TEM-1 genes of E.coli is 48.7% among 
83 isolates of intestinal bacteria producing ESBL including 
E.coli strains, K. pneumonia and entrobacter from clinic 
specimen taken from educational hospitals in Shar e Kord 
[22,23]. This was 50% in our research.  In Taiwan, Chin-
fulin et al. (2010) reported the prevalence of TEM gene in 
69 E.coli isolates [24].  Shazi shaki et al (2010) reported 
that TEM is the most common resistance gene in E.coli of 
Neonatal Intensive Care Units (NICU) of Indian hospitals 
[2]).   
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Conclusions
We found out that 86.9% and %88.89 bla
TEM
 containing E.coli 
isolates resisted ceftazidime and cefotaxime, respectively. 
This represents the role of bla
TEM
 gene in making resistance 
to cephalosporins. With regard to growing increase of 
various types of ESBL enzymes and their unbalanced effects 
on various antibiotics, precise determination of different 
types of TEM enzyme and other ESBL enzymes using other 
molecular methods including PCR-RFLP, REP-PCR and 
sequencing these genes is inevitable. Beta lactam-based 
antibiotics specially, third generation of cephalosporins are 
the main antibiotic therapies in clinical centers. It should 
be noted that increased resistance of pathogenic bacteria to 
these medications particularly ceftazidime and cefotaxime 
(for E.coli) questions the clinical effect of such medications. 
Thus, prescription of antibiotics suited to precise sensitivity 
test are recommended to avoid expansion of this medicinal 
resistance, ESBL secretion, and infections with likely 
ESBL-producing organisms.  
References
1. Joklik WK, Willett  HS, Wilfert C H. (eds) Antimicrobial 
agents. Zinsser Microbiology.    20th ed. Norwalk: Appleton 
and Lange, 2005: 153-87.  
2. Al-Jasser A M. Extended-spectrum beta-lactamases (ESBLs): 
A global problem.Kuwait Med  J 2006;38;171-85. 
3. Medeiros A A.   Evolution and dissemination of ß-lactamases 
accelerated by generations of ß-lactam antibiotics. Clin Infect 
Dis 1997;997:(Suppl 1):S19-45. 
4. Koseoglu O, Kocaguz S, Gur D, Akova M.  Nosocomial blood 
stram infection in Turkish university hospital : Study of Gram-
negative bacilli and their sensitivity patterns, Int J Antimicrob 
Agents  2001;17:477-81.   
5. Rupp M E, Fey P D.  Extended - spectrum beta-lactamse 
(ESBL) producing  Enterobacteriaceae: Consideration for 
diagnosis, prevention and drug treatment. Drugs  2003;63:353-
65.    
6. Thomson K D, Preevan AM, Sanders CC.  Novel plasmed-
mediated beta- lactamases in Enterobacteriaceae: emerging 
problems for new beta-lactam antibiotic.  Curr Clin Top Infect 
Dis  1996;16:151-63.
7. Ensor VM, Livermore DM, Hawkey PM.  A novel reverseline 
hybridization assay for identifying genotypes of CTX-M- 
Typeextended-spectrum beta-lactamases. Antimicrob 
Chemother 2007;59:387-95.
8. Biedenbach  DJ, Lewis MT, Gones RN.  Invitro evaluation 
of cefepime and other road-spectrum p-Iactams for isolates 
in Malaysia and  Singapore Antimicrobial Resistance Study 
group. Diagn Microbiol Infect Dis 1999;35:277- 83.
9. Stürenburg E, Mack D. Extended-spectrum beta-lactamases: 
implications for the clinical microbiology laboratory, therapy, 
and infection control.  J Infect 2003;47:273-95.
10. Lal P, Kapil A, Das B K, Sood  S. Occurrence of TEM and 
SHV gene in extended-spectrum beta- lactamases (  ESBLS ) 
producing Klebsiella  sp. Isolated from a tertiary care hospital. 
Indian  Med   Res 2007;125:173-8.
11. Colom K, Perez J, Alonso R, Aranguiz AF, Larino E, Cisterna 
R. Simple and reiable multiplex PCR assay for detection of 
blaTEM genes in Enterobacteriaceae. FEMS Microbiol Lett 
2003;223:147-51.
12. Zamberi S, Rusmah Y, Rusmah M.  Extended- spectrum 
beta- lactamases- producing  Escherichia coli  from a tertiary 
hospital in Malaysia: emergence of CTX- M- type beta- 
lactamases variation.  Res Microbiol 2008;125: 1-5. 
13. Hosseini-Mazinani SM, Eftekhar F, Milani M, Ghandili S. 
Characterization of beta-lactamases from urinary isolates  of 
Escherichia coli in Tehran.  Iran Biomed J 2007;11:95-9.
14. Masjedian GF, Valehi F, Talebi A,  Rastegar LA. Moulecular 
evaluation of resistance to espanded antibiotics  in  Escherichia 
coli and  Klebsiella pneumoniae. Iran J Med Microbiol 
2007;1:27-34.
15. Mirsalehian A, Akbari-Nakhjavani F, Peymani A, Kazemi 
B, JabalAmeli F, Mirafshar SM.  Prevalence of extended 
spectrum β-lactamase-producing Enterobacteriaceae by 
phenotypic andgenotypic methods in intensive care units in 
Tehran, Iran. Daru 2008;16:169-73.
16. Hernández MS, %ADa%20
JA%225BAuthor%D&itool=EntrezSystem.PEntrez.
Pubmed.Pubmed_ResultsPanel .Pubmed_Discovery 
Panel.Pubmed_RVAbstractPlus”GarcíaHYPERLINK 
“http://www.ncbi.nlm.nih.gov/sitesentrez?Db=pubmed 
& C m d = S e a r c h & T e r m = % 2 2 G a r c % C 3 % A D a % 2 0
J A % 2 2 % 5 B A u t h o r % 5 D & i t o o l = E n t r e z S y s t e m 2 .
PEnt rez .Pubmed .Pubmed_Resu l t sPane l .Pubmed_
DiscoveryPanel.Pubmed_RVAbstractPlus”JA, %Boz%20
JL%225BAuthor%D&itool=EntrezSystem.PEntrez.Pubmed.
Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_
RVAbstractPlus”Muñoz JL In vitro activity of fosfomycin 
against ESBL-producing enterobacteria of urinary origin. Rev 
Esp Quimioter. 2009;22:25-9.
17. Bradford PA. Extended-spectrum beta-lactamases in the 
21stcentury: characterization, epidemiology, and detection 
of thisimportant resistance threat. Clin Microbiol Rev 
2001;14:933-51. doi: 10.1128/CMR.14.4.933-951.2001
18. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular 
epidemiology of extended-spectrum beta-lactamases among 
Escherichia coli isolates collected in a Swedish hospital and 
its associated health care facilities from 2001 to 2006. J Clin 
Microbiol 2008;46:707-12. doi: 10.1128/JCM.01943-07
19. Pai H, Lee HJ, Choi E H,  Kim J, Jacoby GA.  Evolution of 
TEM-related extended-spectrum beta-lactamases in Korea. 
Anti Microb Agent Chemother  2001;45: 3651-3.
20. Pornour  MR, Nahaie Mobaien H, Mobasher Karjedi A. 
Molecular study of Eutended- Spectrum Beta- Lactamaase 
(TEM type) in Escherichia coli and Klebsiella pneumoniae 
isolates from clinical samples, Med J Tabriz Univ Med 
2010;32:30-4. 
21. Soltan Dallal M M, Molla Aghamirzaei H, Fallah Mehrebadi 
J, Rastegar Lari A, Sabbaghi A, Eshraghian MR.  Molecular 
detection of TEM and Ampc (OHA, Mox) broad spectrum 
B- lactamase in clinical isolates.   Tehran Univ Med J 
2010;68:315-20. 
40 Fathi et al.
Extended-spectrum beta-lactamase (TEM-1) gene in E.  Coli isolates Marmara Medical Journal 2016; 29: 35-40
22. Zamanzad B, Deiham B,  molecular detectin of TEM1 
type beta- lactamasegenes in Escherichia coli, Klebsiella 
pnonomoniae, Entr, bacter from clinical Isolated Educational 
hospitals in Shahrkord. J  Hamadan Med Univ  2007;14:27-34.
23. Shojapour M, Shariati L, Karimi A, Zamanzad B. Prevalence 
of TEM-1 type beta-lactamase genes in Pseudomonas 
aeruginosa strains isolated from burn infections using Duplex 
PCR in Shahrekord. 2011:14:55-61. 
24. Lin CF, Hsu SK, Chen CH, Huang JR, Lo HH.  Genotypic 
detection and molecular epidemiology of extended- spectrum 
beta lactamase producing Escherichia coli and Klebsiella 
pneamoniae in a regional hospital in central Taiwan. J Med 
Microbiol  2010; 56:665- 71.  doi: 10.1099/jmm.0.015818-0.
25. Shakil, SH., Akram, M,. et al, 2010. Acguisition of entended- 
spectrum- lactomase produsing Escherichia coli strains in 
male and female infants admitted to a neonatal intensive 
care unit: molecular epidmiogy and analysis of risk factors, 
Journal Med microbial.  59: 948- 954.
